Drugs / 3R 3'R Zeaxanthin
last change Jun 2009 re-read 3 minutes ago

3R 3'R Zeaxanthin

Developed for
age-related macular degeneration

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
— NCT00564902 Comparator Nov 2007 → May 2009 age-related macular degeneration, cognitive disorder Chrysantis, Inc. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 3R 3'R Zeaxanthin ClinicalTrials.gov intervention name — accepted as the source's own label NCT00564902 ↗